Pharmicell Co Ltd
KRX:005690

Watchlist Manager
Pharmicell Co Ltd Logo
Pharmicell Co Ltd
KRX:005690
Watchlist
Price: 10 080 KRW 0.3% Market Closed
Market Cap: 605B KRW
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+66%
Revenue
Forecast
+11%
Operating Income
Forecast
+11%
Net Income
Forecast
+11%

Wall Street
Price Targets

Price Targets Summary
Pharmicell Co Ltd

Wall Street analysts forecast Pharmicell Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Pharmicell Co Ltd is 16 830 KRW with a low forecast of 16 665 KRW and a high forecast of 17 325 KRW.

Lowest Forecast
Wall Street Target
16 665 KRW
65% Upside
Average Forecast
Wall Street Target
16 830 KRW
67% Upside
Highest Forecast
Wall Street Target
17 325 KRW
72% Upside
Lowest
Price Target
16 665 KRW
65% Upside
Average
Price Target
16 830 KRW
67% Upside
Highest
Price Target
17 325 KRW
72% Upside
Pharmicell Co Ltd Competitors:
Price Targets
EXEL
Exelixis Inc
3% Upside
OCX
OncoCyte Corp
31% Upside
K
2162
KeyMed Biosciences Inc
43% Upside
HALO
Halozyme Therapeutics Inc
17% Upside
EXEL
Exelixis Inc
3% Upside
OCX
OncoCyte Corp
31% Upside
K
2162
KeyMed Biosciences Inc
43% Upside
HALO
Halozyme Therapeutics Inc
17% Upside
IGMS
IGM Biosciences Inc
45% Upside
AMGN
Amgen Inc
17% Upside
ARGX
argenx SE
31% Upside
ABBV
Abbvie Inc
17% Upside

Revenue
Forecast

Revenue Estimate
Pharmicell Co Ltd

For the last 8 years the compound annual growth rate for Pharmicell Co Ltd's revenue is 11%. The projected CAGR for the next 2 years is 79%.

11%
Past Growth
79%
Estimated Growth
Estimates Accuracy
-9%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Pharmicell Co Ltd

The compound annual growth rate of Pharmicell Co Ltd's operating income for the next 2 years is 225%.

N/A
Past Growth
225%
Estimated Growth
Estimates Accuracy
-20%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Pharmicell Co Ltd

The compound annual growth rate of Pharmicell Co Ltd's net income for the next 2 years is 199%.

N/A
Past Growth
199%
Estimated Growth
Estimates Accuracy
-42%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Pharmicell Co Ltd's stock price target?
Price Target
16 830 KRW

According to Wall Street analysts, the average 1-year price target for Pharmicell Co Ltd is 16 830 KRW with a low forecast of 16 665 KRW and a high forecast of 17 325 KRW.

What is Pharmicell Co Ltd's Revenue forecast?
Projected CAGR
79%

For the last 8 years the compound annual growth rate for Pharmicell Co Ltd's revenue is 11%. The projected CAGR for the next 2 years is 79%.

What is Pharmicell Co Ltd's Operating Income forecast?
Projected CAGR
225%

The compound annual growth rate of Pharmicell Co Ltd's operating income for the next 2 years is 225%.

What is Pharmicell Co Ltd's Net Income forecast?
Projected CAGR
199%

The compound annual growth rate of Pharmicell Co Ltd's net income for the next 2 years is 199%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 249,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.